|
NEUROCRINE BIOSCIENCES INC
|
3,316,523
|
$128,349,000
|
9.13%
|
New
|
+$128,349,000
|
|
Tesaro Inc
|
687,993
|
$92,521,000
|
6.58%
|
New
|
+$92,521,000
|
|
AMICUS THERAPEUTICS, INC.
|
17,296,672
|
$85,964,000
|
6.12%
|
New
|
+$85,964,000
|
|
Sarepta Therapeutics, Inc.
|
2,769,829
|
$75,976,000
|
5.41%
|
New
|
+$75,976,000
|
|
VERSARTIS
|
4,153,685
|
$61,889,000
|
4.40%
|
New
|
+$61,889,000
|
|
Retrophin, Inc.
|
2,687,412
|
$50,872,000
|
3.62%
|
New
|
+$50,872,000
|
|
NxStage Medical, Inc.
|
1,927,989
|
$50,533,000
|
3.60%
|
New
|
+$50,533,000
|
|
Xencor Inc
|
1,785,018
|
$46,982,000
|
3.34%
|
New
|
+$46,982,000
|
|
Global Blood Therapeutics, Inc.
|
3,128,978
|
$45,213,000
|
3.22%
|
New
|
+$45,213,000
|
|
EAGLE PHARMACEUTICALS, INC.
|
498,198
|
$39,527,000
|
2.81%
|
New
|
+$39,527,000
|
|
Aclaris Therapeutics, Inc.
|
1,260,847
|
$34,219,000
|
2.44%
|
New
|
+$34,219,000
|
|
ARDELYX, INC.
|
1,836,196
|
$26,073,000
|
1.86%
|
New
|
+$26,073,000
|
|
LION BIOTECHNOLOGIES INC
|
3,567,553
|
$24,794,000
|
1.76%
|
New
|
+$24,794,000
|
|
REGENXBIO Inc.
|
1,282,286
|
$23,786,000
|
1.69%
|
New
|
+$23,786,000
|
|
COLUCID PHARMACEUTICALS
|
641,364
|
$23,346,000
|
1.66%
|
New
|
+$23,346,000
|
|
LA JOLLA PHARMACEUTICAL CO
|
1,319,274
|
$23,127,000
|
1.65%
|
New
|
+$23,127,000
|
|
AVEXIS
|
473,531
|
$22,602,000
|
1.61%
|
New
|
+$22,602,000
|
|
DBV Technologies S.A.
|
610,643
|
$21,452,000
|
1.53%
|
New
|
+$21,452,000
|
|
GALAPAGOS NV
|
304,531
|
$20,631,000
|
1.47%
|
New
|
+$20,631,000
|
|
VBI Vaccines Inc/BC
|
6,565,843
|
$20,354,000
|
1.45%
|
New
|
+$20,354,000
|
|
Wave Life Sciences Ltd.
|
665,198
|
$18,088,000
|
1.29%
|
New
|
+$18,088,000
|
|
ANI PHARMACEUTICALS INC
|
267,100
|
$16,192,000
|
1.15%
|
New
|
+$16,192,000
|
|
ACCELERON PHARMA INC
|
619,987
|
$15,822,000
|
1.13%
|
New
|
+$15,822,000
|
|
FOAMIX PHARMACEUTICALS
|
1,322,994
|
$14,685,000
|
1.05%
|
New
|
+$14,685,000
|
|
AVADEL PHARMACEUTICALS PLC
|
1,388,240
|
$14,424,000
|
1.03%
|
New
|
+$14,424,000
|